Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155482 | SCV000205178 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Ser313Ser in exon 5 of DNAH11: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.8% (69/8254) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs72655977). |
Prevention |
RCV000155482 | SCV000307603 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000155482 | SCV000339404 | benign | not specified | 2016-02-22 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000296338 | SCV000468044 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000296338 | SCV000562009 | benign | Primary ciliary dyskinesia | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001310953 | SCV001500951 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | DNAH11: BP4, BP7, BS2 |
Gene |
RCV001310953 | SCV001818127 | likely benign | not provided | 2020-09-07 | criteria provided, single submitter | clinical testing |